載入...
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
Interleukin-6 (IL-6) can induce therapeutic resistance for several cancer agents currently used to treat classical Hodgkin lymphoma (cHL). We aimed to investigate whether the presence of IL-6(+) leukocytes and IL-6(+) Hodgkin-Reed-Sternberg (HRS) cells in the tumor microenvironment (TME) was associa...
Na minha lista:
| 發表在: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993098/ https://ncbi.nlm.nih.gov/pubmed/33720338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003664 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|